The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS
Clinical trial NCT04651855 · UNKNOWN
Trial details
- NCT number
- NCT04651855
- Sponsor
- Polski Bank Komorek Macierzystych JSC (PBKM)
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-03-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.